RGEN

RGEN

Repligen Corp
Life Sciences Tools & Services
$163.84 -2.03% As of Oct 9, 2:49 AM
Loading chart...
Interactive chart powered by TradingView

Technical Analysis

RGEN Fails to Reclaim Moving Averages Near $163.84

Bearish
Oct 9, 2026 at 2:49 AM • $163.84 (-2.03%)

Shares of Repligen Corp (RGEN) declined 2.03% to $163.84 on October 9.

Chart analysis reveals a bearish configuration:

Moving Averages Price sits below both the 9-day ($177.08) and 21-day ($178.29) EMAs, suggesting short-term weakness.
Momentum RSI at 40.2 is neutral but weakening. MACD reads 0.86 against its 3.84 signal line (bearish).
Volatility Bollinger Band width at 21.3% indicates normal volatility.

The $160.99-$199.36 range defines near-term boundaries.

RGEN Tests Lower Support as EMAs Roll Over at $163.84

Bearish
Oct 8, 2026 at 9:01 PM • $163.84 (-2.03%)

RGEN MACD Line Drops Below Signal at $167.22

Bearish
Oct 7, 2026 at 9:01 PM • $167.22 (-4.37%)

Technical Deterioration: RGEN MACD Weakens at $174.86

Bearish
Oct 6, 2026 at 9:02 PM • $174.86 (-7.73%)

RGEN Clears Resistance, EMAs Confirm at $189.50

Bullish
Oct 6, 2026 at 4:53 AM • $189.50 (+4.30%)
Systematic technical analysis • Updated daily after market close

Get Trade Alerts

Receive disciplined options trade ideas with entries, targets & risk management.

Market Summary

Current Price $163.84
Daily Change -2.03%
Sentiment Bearish
Sector Life Sciences Tools & Services
Last Updated Oct 9
Disclaimer: This analysis is for educational purposes only. Options trading involves substantial risk. Past performance does not guarantee future results.